logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Feb 24, 2016

PharmaCyte Biotech on Schedule for 2016 Cancer Clinical Trial in Pancreatic Cancer

  • Feb 22, 2016

PharmaCyte Biotech Issues Update on Preparations for Its Pancreatic Cancer Clinical Trial

  • Feb 10, 2016

Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech

  • Feb 8, 2016

Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment

  • Jan 25, 2016

PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial

  • Jan 19, 2016

PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes

  • Jan 14, 2016

PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial

  • Jan 7, 2016

PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference

  • Jan 4, 2016

PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells July 5, 2022
  • PharmaCyte Biotech Issues Follow-Up Response to Iroquois Capital’s Second Letter on June 9 and Reiterates Commitment to Increasing Shareholder Value June 15, 2022